Opinion: Policymakers’ Harmful Anti-China Obsession

Justifying science funding through the lens of global competition risks fostering racial bias and discrimination.

Written byChristopher Tonnu Jackson
| 3 min read
Puzzle of US and Chinese flags

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, KTSIMAGE

It was easy for scientists to denounce racism last March when an attacker sprayed bullets into Asian-owned spas in Atlanta and murdered eight people, mostly Asian American women. However, the scientific community’s response is starkly different when racism is used to justify a pro-science agenda. Just a few months after the scientific community released statements condemning more than a year’s worth of anti-Asian violence tied to COVID-19, that same racial prejudice fueled a landmark science funding bill—the United States Innovation and Competition Act of 2021 (USICA), formerly known as the Endless Frontier Act. Underlying the bill’s investments in science and technology is an agenda of countering China’s influence.

We shouldn’t condemn Asian hate crimes and tweet about #StopAsianHate in one breath and then use anti-China xenophobia to support increased science funding in the next. Scapegoating China is politically expedient; it allows policymakers on both sides of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Headshot of Christopher Tonnu Jackson

    Christopher Tonnu Jackson is a PhD candidate at the University of California, Berkeley, studying the development of nanomaterial tools for biomolecular delivery. He frequently writes and advocates for public policy related to science, energy, climate, immigration, and equity.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies